Combined Diagnostic Approach for Refractory Mycoplasma Pneumonia in Children

NACompletedINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

December 1, 2022

Primary Completion Date

May 31, 2024

Study Completion Date

May 31, 2024

Conditions
Refractory Mycoplasma Pneumoniae Pneumonia
Interventions
PROCEDURE

Bronchoscopy with Bronchoalveolar Lavage

Flexible bronchoscopy to assess airway patency, remove mucous plugs, and collect bronchoalveolar lavage (BAL) fluid for microbiological and cytological analysis.

PROCEDURE

Chest CT with Scoring

Chest CT scans at baseline and day 14 to quantitatively assess lesion range, lesion type, pleural effusion, and lymphadenectasis (Total score: 0-13).

DIAGNOSTIC_TEST

Monocyte Subpopulation Analysis

Flow cytometry analysis of peripheral blood to phenotype monocyte subsets (Classical, Intermediate, Non-classical) at baseline and day 14 to guide immunomodulatory therapy.

DRUG

Azithromycin, Doxycycline, Prednisone

Sequential azithromycin as baseline therapy. Doxycycline (4 mg/kg/day) was used if BAL results confirmed azithromycin resistance. Oral prednisone (1 mg/kg/day for 5 days) was added if intermediate monocytes were \>15%.

OTHER

Supportive Care

Management of cough, wheezing, and fever based on clinical symptoms.

Trial Locations (1)

050031

Hebei Children's Hospital, Shijiazhuang

All Listed Sponsors
lead

Children's Hospital of Hebei Province

OTHER